FDA DISCOURAGES LOVASTATIN-GEMFIBROZIL COMBINATION.

@inproceedings{Thl1990FDADL,
  title={FDA DISCOURAGES LOVASTATIN-GEMFIBROZIL COMBINATION.},
  author={Thl},
  year={1990}
}
Lovastatin and gemfibrozil are among the most commonly used drugs for cholesterol reduction. In this report, the Food and Drug Administration describes 

Topics from this paper.

Similar Papers